2019 Exhibitors


Booth 2: MIM Software Inc
MIM Software Inc. offers a powerful combination of tools available for:

  • Prostate LDR Brachytherapy TPS for all ultrasound manufacturers and direct connection with BK Ultrasound®.
  • Breast Microseed Treatment® software exclusively from Concure Oncology®.
  • MRI-guided fusion integrated with BK Ultrasound for those optimizing HDR implantation.
  • CT, US, and MRI fusion integration into treatment planning for enhanced planning accuracy, quality assurance, and timesavings.

The MIM Software advantage comprises a complete pathway solution for prostate cancer and breast cancer management. Please visit https://www.mimsoftware.com/ for prostate fusion and LDR products and http://www.breastmicroseed.com/ for Concure Oncology.


Booth 5: Varian Medical Systems
Varian Medical Systems focuses energy on saving lives by equipping the world with advanced technology for fighting cancer. The company is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiation. The company provides comprehensive solutions for radiotherapy, radiosurgery, proton therapy and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. For more information, visit www.varian.com/brachytherapy.


Booth 6: Mobius
Mobius Imaging is the premier developer and supplier of best-in-class large bore diagnostic and intraoperative mobile CT imaging systems. Its Airo® 32 slice mobile, wide bore CT System provides intra-procedural diagnostic imaging supporting radiation therapy applications including brachytherapy.


Booth 8: Pyrexar Medical
Pyrexar Medical is the recognized global leader in thermal oncology medical devices. Our clinically proven systems provide targeted hyperthermia to solid tumors that increase the effectiveness of radiotherapy in the treatment of cancer. Hyperthermia provides increased blood flow and perfusion, shrinks tumor mass, inhibits DNA repair and can trigger and immune response. We offer systems that treat deep regionally, superficially and interstitially.


Booth 9: Boston Scientific-SpaceOAR


Booth 10 and 11: Qfix
Qfix is an innovative medical device company focused on discovering, developing and commercializing technology-driven solutions that are compatible in modalities ranging from linear accelerators, proton therapy, and imaging technologies. Qfix's primary focus is designing patient positioning and immobilization solutions that meet the unique physics of photon and proton beam transmission and allow for high precision treatment through reduced intra- and inter-fraction patient movement. We advance precise positioning solutions for cancer treatment by fostering a deep engagement with medical professionals. With the learning and relationships built from these deep ties, we are aggressively pursuing many cutting edge solutions, including Stereotactic Radiosurgery (SRS), Stereotactic Body Radiation Therapy (SBRT), Magnetic Resonance (MR) and Patient Transport. Log on to www.Qfix.com for more information.


Booth 12: IsoAid
As the manufacturer of Advantage™ I-125 and Pd-103 seeds for over 15 years, IsoAid specializes in providing brachytherapy seeds for the treatment of prostate, ocular and breast cancer, as well as for diagnostic localization purposes. We are a full-service company you can always rely on, making seeds at the activity you request, custom-loading and delivering them faster than anyone in the industry. Through our exclusive partnership with Eye Physics we give you access to cutting edge eye plaques and planning services, which deliver many clinical advantages to you and your patients. High-activity seeds are custom-loaded using COMS or Eye Physics plaques. Our innovate Secure Strand™, cuts down significantly on migration for prostate patients and is now being used for RSL with great success. Our team of experts is dedicated to helping with every aspect of your program and serves as a complete resource for you. IsoAid is invested in the future of Brachytherapy and we look forward to introducing you to some exciting new advances very soon.


Booths 13: CivaTech Oncology
CivaTech Oncology is a medical device company dedicated to localized radiation, precision therapy without the beam. The implantable CivaSheet features a polymer encapsulated Pd-103 source, the only LDR brachytherapy device customizeable to a specific patient and unidirectional to shield healthy tissue- Gold is Cold! CivaString is also a Pd-103 source with a unique linear radioactive distribution providing refinement on traditional prostate seeds- less needles, less swelling, fast recovery.


Booth 14: IsoRay
Isoray Medical passionately designs and develops innovative and personalized brachytherapy products that effectively treat many forms of cancer. We believe in pioneering solutions for life beyond your cancer.

Founded in 1998 to explore the medical use of Cesium 131 for the treatment of prostate cancer, Isoray's low dose rate (LDR) brachytherapy product was cleared by the FDA for treatment of various cancers. Since the first patient was treated with Isoray's Cesium product in October 2004, Isoray has provided products for over 10,000 patient treatments, including prostate cancer, brain, head & neck and gynecological tumors, and other isolated tumors and tumor beds.

Isoray has a dedicated team of employees who passionately work together to design, develop, produce and deliver products to address clinical needs and push the industry status quo with highly efficacious and patient-centric treatments.

IsoRay logo


Hitachi Booth 15: Hitachi Healthcare
Hitachi Healthcare's commitment to ultrasound in urology offers a wide range of consoles and specifically designed transducers to meet the needs of every doctor. Recognized for our superior image quality, system reliability and use of cutting edge technology, we remain the standard in the field of ultrasound.


Booths 16 & 17: Samsung Neurologica
NeuroLogica, a subsidiary of Samsung, brings the power of innovative imaging to your patients. With an expertise in CT design, NeuroLogica transforms fixed CT technologies into portable platforms used in many different clinical applications. The world's first portable, full body CT scanner, BodyTom is a self-shielded, multi-departmental imaging solution capable of transforming any room in the hospital into an advanced CT suite. The system features an 85cm gantry and a 6cm field of view, the largest field of view available in a portable CT scanner. BodyTom provides point-of-care imaging wherever high-quality CT images are needed, including the intensive care unit and radiation oncology suites. For more information, please visit www.NeuroLogica.com.


Booth 18: Theragenics
As an industry pioneer and leader, Theragenics has an unparalleled history of > 35 years in the manufacture and global supply of low-dose rate (LDR) brachytherapy seeds for the treatment of prostate cancer, lung cancer, intra-ocular malignancies, benign disease, and other solid tumors.  Theragenics continues to invest and develop innovative brachytherapy solutions, supported by the recent launch of Orion™, a novel, positive-signal MRI marker for HDR treatment planning. Please contact us to learn more about our industry benchmark recognized sources TheraSeed® Pd-103 & AgX100® I-125, and Orion MRI HDR Line Marker.


Booth 19: C4 Imaging LLC
C4 Imaging develops innovative medical devices that enable clinicians to personalize patient treatment through accurate MRI guided procedures. LDR post-implant seed localization is achieved with the Sirius™ MRI Marker, along with a new MRI line marker for HDR planning. The company's core proprietary technology, C4, is a unique magnetic resonance imaging (MRI) agent that is encapsulated within a biocompatible shell.


Booth 25: Elekta
Elekta pioneers significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, stateo-f-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care.

Encompassing forty years innovation, Elekta's brachytherapy solutions are designed for precise, targeted treatment of various cancers such as prostate, breast, skin and surface, rectum and gynecological anatomy. The best-in-class clinical solutions include Flexitron® afterloading, Oncentra® Brachy treatment planning, Esteya® electronic brachytherapy, the broadest range of applicators in the industry and Real-time Prostate Solutions. To learn more, visit www.elekta.com/brachytherapy.


Tabletop Exhibitors


Tabletop A: AccuBoost
AccuBoost® is an innovative radiotherapy procedure: It uses real-time mammography image-guidance for targeting the radiation and a non-invasive HDR brachytherapy approach for delivering a conformal dose. Slight compression of the breast via a mammography platform allows the external tungsten applicators to be placed close to the tumor bed, minimizing exposure to healthy tissue for good cosmetic outcome.


Tabletop F: GT Medical Technologies
GT Medical Technologies is committed to improving the lives of patients with brain tumors. Driven to overcome the limitations of current treatments and raise the standard of care, a group of brain tumor specialists joined forces and formed GT Medical Technologies to address this critical, unmet need. Extensive clinical expertise informed the design of GammaTile, which is a surgically targeted radiation therapy (STaRT) that provides immediate, dose-intense treatment at completion of brain tumor resection.


Tabletop G: CIVCO Medical Solutions
For over 30 years CIVCO Medical Solutions has been an industry leader in ultrasound, providing needle guidance solutions and infection control products across the spectrum of care. CIVCO offers a full range of steppers, stabilizers and accessories for transrectal and transperineal procedures.


Tabletop I: Myriad Medical LLC
Myriad Medical is a leading device company that develops treatment aids for radiation delivery. We develop simple solutions with the most clinically advanced technology to enhance the standard of care each patient deserves. For 8 years our prostate immobilization devices have been recognized for their non-invasive approach to reduce rectal toxicity. Myriad Medical's rectal balloon can reduce rectal dose and intra-fraction motion.

We understand the urgency for quality care when patients are diagnosed with cancer and the responsibility of medical professionals to provide the most advanced resources. Our devices are designed with cost effectiveness in mind, making our leading technology more accessible to healthcare providers nationwide.


Tabletop O: Alpha TAU Medical Ltd.
Alpha TAU Medical is an Israeli company focusing on research, development and commercialization of Alpha DaRT® (Diffusing Alpha-Emitters Radiation Therapy) that enables the use of highly potent and conformal alpha radiation in brachytherapy. The Alpha DaRT technology which was initially developed at the Tel Aviv University, has been tested in numerous pre-clinical studies and has been shown to be an effective and safe approach for treating different types of solid tumors. These findings have been published in 12 papers in peer-reviewed scientific journals.

Alpha TAU Medical has recently initiated its first clinical studies in squamous cell carcinoma patients in Israel and in Italy. In addition, the company is in the process of starting additional clinical trials in patients with prostate cancer, breast cancer, rectal cancer, gynecological cancer and pancreatic cancer. http://www.alphataumedical.com/ .